Delivery Order SPE2DB20D2104-SPE2DB23FU43Y
Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $128
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $63,750 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561327178 pioglitazone HCl 15 mg tablets. As a major pharmaceutical supplier, Amerisourcebergen will deliver 90 units of the specified medication to a facility in Conshohocken, Pennsylvania by June 26, 2023 in support of the Defense Logistics Agency's medical logistics programs. No subcontractors or set aside designations were identified in the award...
- The Defense Logistics Agency Troop Support Medical awarded a $86,640 delivery order to Amerisourcebergen Drug Corporation for 30,000 pioglitazone hydrochloride 30 mg tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by July 28, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $1,241.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of pioglitazone hydrochloride 45 mg. The contract has a period of performance from June 27, 2023 through June 28, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals to the Department of Defense, this small order for diabetes medication supports the Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,554 to Amerisourcebergen Drug Corporation for the supply of 500 pioglitazone hydrochloride 30 mg tablets. The order was placed under an existing prime vendor contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania over a three-day period concluding on July 17, 2023. No...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty-one dollars and forty-two cents to Amerisourcebergen Drug Corporation for pioglitazone hydrochloride 45 mg tablets. Under the contract, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required from July 17 through July 18, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for...
- The Defense Logistics Agency awarded a $151,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562252833 pioglitazone hydrochloride 45 mg tablets. Under this contract, Amerisourcebergen will deliver 30 tablets of the specified medication to an address in Conshohocken, Pennsylvania by September 21, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and its military services, suggesting this...
- The Defense Logistics Agency awarded a $32,490 delivery order to Amerisourcebergen Drug Corporation for 4561926662 pioglitazone hydrochloride 30 mg tablets. The firm fixed price order is for 30 tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No set aside designation or subcontractors were identified. Amerisourcebergen will provide the pioglitazone tablets...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,804.19 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,847.10 for Pioglitazone HCL 45 mg tablets (90-count) on September 23, 2025, with a completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, a comprehensive $1...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units) valued at $2,474.49. This non-competitive delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a firm fixed-price transaction under an existing contract vehicle, reflecting the agency's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU43YDelivery Order
The Defense Logistics Agency awarded a $127,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90,000 pioglitazone hydrochloride 15 mg tablets. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the ordered medications from its facility in Conshohocken, Pennsylvania to an unspecified customer within the DLA supply chain network. The delivery order was issued on July 18, 2023 under an existing DLA pharmaceutical supply contract vehicle and carries a period of performance through July 19, 2023. No set-aside designations or subcontracting arrangements were indicated in the award information provided.
Generated 12/15/23, 3:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $128 | 7/18/23 |